Edition:
United States

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

74.41USD
14 Dec 2017
Change (% chg)

$-2.01 (-2.63%)
Prev Close
$76.42
Open
$76.88
Day's High
$76.95
Day's Low
$74.37
Volume
43,657
Avg. Vol
110,302
52-wk High
$120.01
52-wk Low
$74.01

Latest Key Developments (Source: Significant Developments)

China Biologic posts Q3 adj. earnings per share $1.38
Wednesday, 1 Nov 2017 04:30pm EDT 

Nov 1 (Reuters) - China Biologic Products Holdings Inc :China Biologic reports unaudited financial results for the third quarter of 2017.Q3 adjusted non-GAAP earnings per share $1.38.Q3 earnings per share $1.11.Q3 sales rose 15.1 percent to $99.6 million.China Biologic Products Holdings Inc - ‍reiterates full year non-GAAP adjusted net income forecast​.China Biologic Products Holdings - ‍adjusting FY 2017 forecast of total sales growth to 9 pct-10 pct in RMB terms compared to previous estimates of 13 pct-15 pct​.  Full Article

China Biologic agrees to acquire Tianxinfu from PWM
Thursday, 12 Oct 2017 08:30am EDT 

Oct 12 (Reuters) - China Biologic Products Holdings Inc :China Biologic agrees to acquire Tianxinfu from PWM.China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​.China Biologic Products - ‍In exchange for acquisition of 80% equity interest in Tianxinfu from PWM, Cbpo will issue 5.5 million ordinary shares to PWM​.China Biologic Products - ‍PWM is expected to hold approximately 16.66% of outstanding share capital of Cbpo taking into effect new issuance​ post deal.China Biologic Products - Board determined to exempt deal from causing PWM to be deemed "acquiring person" under CBPO's preferred shares rights agreement​.China Biologic Products Holdings Inc - ‍Acquire 80% equity interest in Tianxinfu from PW Medtech Group Limited​.China Biologic Products - ‍CBPO elected to be exempted from shareholder approval requirement under applicable rules of nasdaq market for proposed deal.China Biologic Products Holdings - ‍Elected to be exempted from shareholder approval requirement under applicable rules of Nasdaq stock market for deal.China Biologic Products Holdings Inc - ‍Post deal close, PWM expected to hold about 16.66% of share capital of co taking into effect new issuance​.  Full Article

China Biologic receives approval for commercial manufacturing of human fibrinogen
Monday, 9 Oct 2017 08:30am EDT 

Oct 9 (Reuters) - China Biologic Products Holdings Inc :China Biologic receives approval for commercial manufacturing of human fibrinogen.China Biologic Products Holdings Inc - ‍expects first batch of products to be released to market by end of 2017​.China Biologic Products Holdings Inc - ‍expect to see meaningful profit contribution from fibrinogen in 2018​.China Biologic Products Holdings - unit received approval from China food and drug administration for commercial manufacturing of human fibrinogen.  Full Article

China Biologic reports Q1 earnings per share $1.06
Wednesday, 3 May 2017 04:45pm EDT 

May 3 (Reuters) - China Biologic Products Inc :China Biologic reports financial results for the first quarter of 2017.Q1 adjusted non-GAAP earnings per share $1.32.Q1 earnings per share $1.06.Sees FY 2017 sales up 13 to 15 percent.Q1 sales rose 6.9 percent to $91.5 million.China Biologic Products Inc -Reiterates full year financial forecast.China Biologic Products Inc says inventories increased by $9.1 million in Q1 of 2017.  Full Article

China Biologic reports Q1 earnings per share $1.06
Wednesday, 3 May 2017 04:45pm EDT 

May 3 (Reuters) - China Biologic Products Inc :China Biologic reports financial results for the first quarter of 2017.Q1 adjusted non-GAAP earnings per share $1.32.Q1 earnings per share $1.06.Sees FY 2017 sales up 13 to 15 percent.Q1 sales rose 6.9 percent to $91.5 million.China Biologic Products Inc -Reiterates full year financial forecast.China Biologic Products Inc says inventories increased by $9.1 million in Q1 of 2017.  Full Article

China Biologic Q4 adjusted non-GAAP earnings per share $0.95
Thursday, 23 Feb 2017 05:00pm EST 

China Biologic Products Inc : China Biologic reports financial results for the fourth quarter and fiscal year 2016 . Q4 adjusted non-GAAP earnings per share $0.95 . Q4 earnings per share $0.69 . Q4 sales rose 13.6 percent to $77.6 million . China Biologic Products says expects total sales to grow 13% to 15% in RMB terms for 2017 .China Biologic Products Inc sees 2017 non-GAAP adjusted net income to grow 18% to 20% in RMB terms.  Full Article

China Biologic Q4 adjusted non-GAAP earnings per share $0.95
Thursday, 23 Feb 2017 05:00pm EST 

China Biologic Products Inc : China Biologic reports financial results for the fourth quarter and fiscal year 2016 . Q4 adjusted non-GAAP earnings per share $0.95 . Q4 earnings per share $0.69 . Q4 sales rose 13.6 percent to $77.6 million . China Biologic Products says expects total sales to grow 13% to 15% in RMB terms for 2017 .China Biologic Products Inc sees 2017 non-GAAP adjusted net income to grow 18% to 20% in RMB terms.  Full Article

Baillie Gifford & Co reports 5.21 pct passive stake in China Biologic Products
Friday, 13 Jan 2017 09:04am EST 

China Biologic Products Inc :Baillie Gifford & Co reports 5.21 percent passive stake in China Biologic Products Inc as of december 31 - sec filing.  Full Article

Baillie Gifford & Co reports 5.21 pct passive stake in China Biologic Products
Friday, 13 Jan 2017 09:04am EST 

China Biologic Products Inc :Baillie Gifford & Co reports 5.21 percent passive stake in China Biologic Products Inc as of december 31 - sec filing.  Full Article

China Biologic Products says reiterates its full year forecast of total sales growth
Wednesday, 4 Jan 2017 08:30am EST 

China Biologic Products Inc : China Biologic Products says reiterates its full year forecast of total sales growth of 22 pct to 24 pct in rmb terms . China Biologic Products says reiterates its full year forecast of non-GAAP adjusted net income growth of 33 pct to 35 pct in rmb terms .China Biologic Products sees total sales,non-GAAP adjusted net income in USD terms in 2016 will be adversely affected by foreign currency translation impact.  Full Article

BRIEF-China Biologic posts Q3 adj. earnings per share $1.38

* China Biologic reports unaudited financial results for the third quarter of 2017